Search
Searching Content indexed under Food and Drugs Law by Mayer Brown ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
European Union
13 Dec 2018
2
Potential EU-UK Competition Law Divergence Post- Brexit Highlighted By Conflicting Approaches Of UK Competition Appeal Tribunal In Recent Pharma Cases
The UK Competition Appeal Tribunal (the "CAT") has recently issued two judgments relating to anticompetitive practices in the pharmaceutical sector, namely:
UK
20 Aug 2018
3
European Commission's Update Of Guideline On Duplicate Marketing Authorizations To Cover Biosimilars
On May 18, 2018, the European Commission launched a public consultation on "Duplicate Marketing Authorisation for Biological Medicinal Products" in relation to updating its Note...
European Union
31 May 2018
4
European Commission Issues Notice On Brexit's Implications For Pharmaceutical Companies
On May 2, the European Commission published a Notice to Marketing Authorisation Holders of Centrally Authorised Medicinal Products.
UK
11 May 2017
5
European Commission Publishes Revised Guidelines On Criteria For Orphan Designations Of Medicinal Products
The eligibility is based on the risk of EU residents becoming affected by the disease.
European Union
12 Jan 2017
6
European Commission Publishes Revised Guideline On Criteria For Orphan Designation Of Medicinal Products
Two important developments occurred in mid-November 2016 for the pharmaceutical industry in Europe: the European Commission published a revised guideline on orphan medicinal products...
European Union
5 Dec 2016
Links to Result pages
 
1